FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998615627> ?p ?o ?g. }

• W1998615627 endingPage "102" @default.
• W1998615627 startingPage "91" @default.
• W1998615627 abstract "Ellipticine, an alkaloid isolated from Apocyanaceae plants, has been shown to exhibit antitumor activity in several human malignant tissues including breast, thyroid, and ovarian cancers. The antitumor activity of ellipticine is thought to be primarily mediated by the induction of DNA damage through the inhibition of topoisomerase II and formation of DNA adducts. The human endometrium is known to express topoisomerase II. However, the apoptogenic activity of ellipticine and the mechanisms underlying its action have not been investigated in endometrial cancer cells. In the present study, exposure to ellipticine (1–10 μM) was shown to induce apoptosis in RL95-2 human endometrial cancer cells. Ellipticine-induced cell death was associated with the accumulation of cells in the G2/M phase of the cell cycle and was accompanied by depolarization of the mitochondrial membrane potential, release of cytochrome c and apoptosis-inducing factor (AIF) from the mitochondrial membrane, and caspase activation. The production of intracellular reactive oxygen species (ROS) was increased and sustained at high levels during ellipticine treatment. Subsequent to ROS accumulation, extracellular-signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) were activated in ellipticine-treated cells. Release of AIF from the mitochondria appeared to be affected by caspases, ROS, and ERK. The present data show that the treatment of RL95-2 cells with ellipticine induces apoptosis, ellipticine-induced apoptosis is mediated by ROS and the activation of MAPKs, and release of AIF is involved in a caspase-independent pathway. These results demonstrate the potential of ellipticine as a therapeutic strategy for the treatment of human endometrial cancers." @default.
• W1998615627 created "2016-06-24" @default.
• W1998615627 creator A5011900177 @default.
• W1998615627 creator A5015389392 @default.
• W1998615627 creator A5028974899 @default.
• W1998615627 creator A5038488422 @default.
• W1998615627 creator A5051627423 @default.
• W1998615627 creator A5061629380 @default.
• W1998615627 creator A5063114246 @default.
• W1998615627 creator A5064363666 @default.
• W1998615627 creator A5066019740 @default.
• W1998615627 creator A5088156448 @default.
• W1998615627 date "2011-11-01" @default.
• W1998615627 modified "2023-09-30" @default.
• W1998615627 title "Ellipticine induces apoptosis in human endometrial cancer cells: The potential involvement of reactive oxygen species and mitogen-activated protein kinases" @default.
• W1998615627 cites W1965147058 @default.
• W1998615627 cites W1966853119 @default.
• W1998615627 cites W1970923300 @default.
• W1998615627 cites W1972636570 @default.
• W1998615627 cites W1973078771 @default.
• W1998615627 cites W1977122455 @default.
• W1998615627 cites W1985496352 @default.
• W1998615627 cites W1986256719 @default.
• W1998615627 cites W1989944572 @default.
• W1998615627 cites W1995819749 @default.
• W1998615627 cites W2009707997 @default.
• W1998615627 cites W2010845266 @default.
• W1998615627 cites W2015424171 @default.
• W1998615627 cites W2016521087 @default.
• W1998615627 cites W2021693564 @default.
• W1998615627 cites W2030276356 @default.
• W1998615627 cites W2031291993 @default.
• W1998615627 cites W2032089911 @default.
• W1998615627 cites W2033445808 @default.
• W1998615627 cites W2033473694 @default.
• W1998615627 cites W2041455059 @default.
• W1998615627 cites W2041901579 @default.
• W1998615627 cites W2047418898 @default.
• W1998615627 cites W2047431110 @default.
• W1998615627 cites W2051390434 @default.
• W1998615627 cites W2059192510 @default.
• W1998615627 cites W2061799336 @default.
• W1998615627 cites W2069161814 @default.
• W1998615627 cites W2092999710 @default.
• W1998615627 cites W2101164773 @default.
• W1998615627 cites W2101372104 @default.
• W1998615627 cites W2103252941 @default.
• W1998615627 cites W2111015378 @default.
• W1998615627 cites W2121082164 @default.
• W1998615627 cites W2123455365 @default.
• W1998615627 cites W2133540072 @default.
• W1998615627 cites W2143543283 @default.
• W1998615627 cites W2151501496 @default.
• W1998615627 cites W2158734599 @default.
• W1998615627 cites W2330899520 @default.
• W1998615627 cites W4292820908 @default.
• W1998615627 doi "https://doi.org/10.1016/j.tox.2011.07.014" @default.
• W1998615627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21843585" @default.
• W1998615627 hasPublicationYear "2011" @default.
• W1998615627 type Work @default.
• W1998615627 sameAs 1998615627 @default.
• W1998615627 citedByCount "44" @default.
• W1998615627 countsByYear W19986156272013 @default.
• W1998615627 countsByYear W19986156272014 @default.
• W1998615627 countsByYear W19986156272015 @default.
• W1998615627 countsByYear W19986156272016 @default.
• W1998615627 countsByYear W19986156272017 @default.
• W1998615627 countsByYear W19986156272018 @default.
• W1998615627 countsByYear W19986156272019 @default.
• W1998615627 countsByYear W19986156272020 @default.
• W1998615627 countsByYear W19986156272021 @default.
• W1998615627 countsByYear W19986156272022 @default.
• W1998615627 countsByYear W19986156272023 @default.
• W1998615627 crossrefType "journal-article" @default.
• W1998615627 hasAuthorship W1998615627A5011900177 @default.
• W1998615627 hasAuthorship W1998615627A5015389392 @default.
• W1998615627 hasAuthorship W1998615627A5028974899 @default.
• W1998615627 hasAuthorship W1998615627A5038488422 @default.
• W1998615627 hasAuthorship W1998615627A5051627423 @default.
• W1998615627 hasAuthorship W1998615627A5061629380 @default.
• W1998615627 hasAuthorship W1998615627A5063114246 @default.
• W1998615627 hasAuthorship W1998615627A5064363666 @default.
• W1998615627 hasAuthorship W1998615627A5066019740 @default.
• W1998615627 hasAuthorship W1998615627A5088156448 @default.
• W1998615627 hasConcept C121608353 @default.
• W1998615627 hasConcept C143425029 @default.
• W1998615627 hasConcept C184235292 @default.
• W1998615627 hasConcept C185592680 @default.
• W1998615627 hasConcept C190283241 @default.
• W1998615627 hasConcept C29311851 @default.
• W1998615627 hasConcept C31573885 @default.
• W1998615627 hasConcept C48349386 @default.
• W1998615627 hasConcept C54355233 @default.
• W1998615627 hasConcept C552990157 @default.
• W1998615627 hasConcept C55493867 @default.
• W1998615627 hasConcept C57074206 @default.
• W1998615627 hasConcept C86803240 @default.
• W1998615627 hasConcept C95444343 @default.

• next